(Q41708979)

7 October 2017

1 reference

title

The role of autologous natural killer cells in chronic myelogenous leukemia (English)

1 reference

7 October 2017

1 reference

Pierson BA

1

1 reference

PubMed ID

9477121

7 October 2017

Miller JS

series ordinal

2

1 reference

7 October 2017

1 November 1997

1 reference

7 October 2017

1 reference

7 October 2017

27

1 reference

7 October 2017

5-6

1 reference

7 October 2017

387-399

1 reference

Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma

7 October 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Population dynamics of human activated natural killer cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Natural killer lymphocyte blast crisis of chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Production of human natural killer cells for adoptive immunotherapy using a computer-controlled stirred-tank bioreactor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Transforming growth factor-beta complexes with thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Natural killer cell proliferation is dependent on human serum and markedly increased utilizing an enriched supplemented basal medium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709058306

10.3109/10428199709058306

21 January 2018

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9477121